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ALI = acute lung injury; CFTR = cystic fibrosis transmembrane conductance regulator.
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Manocha and colleagues [1] found in a retrospective study
on the association of beta-agonist use and lung injury a
shorter duration and less severity of lung injury in patients on
aerosolized beta-agonists. In their discussion of possible
causes they and the investigators of the beta-agonist lung
injury trial [2] did not comment on the effect of beta-agonist
treatment on pulmonary chloride transport as an important
independent determinant of pulmonary fluid clearance. It was
first noted in experiments by Fang and colleagues [3] that
mice with inhibited or defective cystic fibrosis trans-
membrane conductance regulator (CFTR) chloride channels
(delta F508 homozygous) have a reduced cAMP dependent
and CFTR mediated pulmonary fluid clearance and more
severe pulmonary oedema in the fluid overload pulmonary
oedema model. This group then established that CFTR is
present in alveolar epithelial cells and contributes indepen-
dently to cAMP dependent fluid transport [4]. Other groups
found that chloride channels in respiratory epithelial cells
can be activated by beta agonists via an increase in
intracellular cAMP [5]. We measured the nasal potential
difference and the amiloride (ENaC blocker) response of the
nasal respiratory epithelium, which both represent upper
airway epithelial sodium transport, and the response of the
nasal respiratory epithelium to a low chloride solution (CFTR
stimulation), which represents chloride channel function in
the upper airway of children with meningococcal
septicaemia related pulmonary oedema [6]. We found that
nasal potential difference and amiloride response were not
different between children with and without meningococcal
septicaemia related pulmonary oedema. Response of the
upper airway epithelium to a low chloride solution was,
however, absent in children with septicaemia related
pulmonary oedema and this was significantly different to
children ventilated for other forms of critical illness without
pulmonary oedema. This indicated that the systemic
reduction of epithelial chloride transport we found in the
children with septicaemia induced pulmonary oedema, which
was also reflected in increased sweat and saliva chloride
levels, extended to the respiratory tract. The reduction in
chloride transport seemed to be more closely related to
pulmonary oedema and its severity than features of sodium
transport. Topical stimulation of chloride channels in the
nasal airway of the children with pulmonary oedema with the
beta agonist isoprenaline resulted in activation of chloride
transport. Future trials and laboratory research related to
treatment of pulmonary oedema needs to take into account
parameters reflecting pulmonary epithelial chloride transport
as important additional explanatory outcomes.
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Authors’ response
Anthony C Gordon and James A Russell
We thank Dr Eisenhut for his comments about our recent
publication that demonstrated an association between
inhaled beta-agonist use and improvement in acute lung injury
(ALI) [1]. Dr Eisenhut and colleagues’ recent work studying
children with meningococcal septicemia found that reduced
epithelial chloride transport was associated with pulmonary
edema in this condition [6]. Interestingly, although only
reported in two children, the inactivation of the chloride
channel was reversed when the airway epithelium was
perfused with the beta-agonist isoprenaline.
Unfortunately, the nature of our retrospective study means we
can only report the association of beta-agonist use and
improvement of ALI, without providing definitive answers toexplain the mechanism of this effect. As discussed, possible
mechanisms include improved respiratory mechanics,
reduced inflammation and improved edema clearance. If the
finding of reversibly impaired chloride transport is seen in
lung injury due to other infectious and non-infectious
etiologies then this is another potential mechanism by which
beta-agonists might improve fluid clearance and thus support
the findings of our study [1] and the beta-agonist lung injury
trial [2].
Hopefully future studies will include randomized controlled
trials to demonstrate if beta-agonists are an effective
treatment in ALI and also mechanistic experiments to explain
any therapeutic effect.
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